FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 2

Author

Admin 422 posts 0 comments

Featured News

AI-Powered Fintech Revolution Reshapes Global Banking and Payments in 2026

Admin Apr 24, 2026
The global fintech industry in 2026 is undergoing a rapid transformation driven by artificial intelligence,…
Articles

AI in Banking: A Review of the Top 7 Banks in America

Admin Apr 23, 2026
Even the established banks are beginning to show interest in and implement artificial intelligence (AI), despite…
Featured News

Volatility Surges as Global Events Reshape Currency Markets

Admin Apr 22, 2026
The global forex trading landscape in 2026 is witnessing heightened volatility as geopolitical tensions, central…
Articles

Cylinder Crisis in India: Rising LPG Costs Push Households Toward Financial Strain

Admin Apr 21, 2026
India is currently witnessing a growing concern over the rising cost and accessibility of domestic LPG cylinders,…
Articles

The Best Advanced Payment Options You Should Be Aware Of

Admin Apr 16, 2026
Essential Payment Solutions for Your Business Running a business involves many considerations, with payment…
Articles

Will fintech impact daily life in Asia and Africa?

Admin Apr 15, 2026
The contemporary world is ever-evolving and provides society with more resources than in the past. Millions of…
Featured News

Fintech Innovation Accelerates in 2026 as Digital Payments and AI Redefine…

Admin Apr 14, 2026
The fintech industry is witnessing rapid evolution in 2026, driven by the growing adoption of digital payments,…
Featured News

US Dollar vs Indian Rupee in 2026: Currency Pressure Continues to Shape India’s…

Admin Apr 13, 2026
In 2026, the ongoing battle between the US Dollar and the Indian Rupee remains a key focus for economists,…
Upcoming conference

The Future of Finance: Navigating Innovation, Risk, and Global Growth

Admin Apr 10, 2026
The global finance industry is gearing up for a dynamic year ahead, with several high-impact conferences set to…
Whitepaper

DRIVING SALESFORCE FINANCIAL SERVICE CLOUD ADOPTION IN BANKS

Admin Apr 9, 2026
While it may seem like common sense alone would influence end users to adopt the superior FSC tools that you are…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Embedded banking but not as you know it
    • How Smart Money Management and Digital Trends Are Reshaping Wealth in 2026
    • INVESTMENT GUIDE Investing for your future
    • 5 Approaches to Scaling Finance Accuracy with AI
    • Understanding the Financial Interest Clause

    ARTICLE

    Candel Therapeutics to Present at Upcoming Investor Conferences
    2026-05-13T12:05:00Z
    NEEDHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) --  Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve outcomes for...


    Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
    2026-05-13T12:00:00Z
    WALTHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF),...


    Century Therapeutics Reports First Quarter Financial Results and Business Updates 
    2026-05-13T12:00:00Z
    PHILADELPHIA, May 13, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes,...


    Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center
    2026-05-13T12:00:00Z
    Silexion advances toward Phase 2/3 trial in KRAS-driven pancreatic cancer, as SIL204 begins GMP clinical manufacturing in collaboration with global leading manufacturing partner Catalent at its European center of excellence


    Dr. Jonathan Gavras Joins Healthmap Solutions as Chief Medical Officer
    2026-05-13T12:00:00Z
    TAMPA, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- Healthmap Solutions (Healthmap), a leading kidney population health management company, has announced the appointment of Jonathan Gavras, MD, FCCP as Chief Medical...


    Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
    2026-05-13T12:00:00Z
    WEST CHESTER, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological diseases, including skin...


    ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026
    2026-05-13T12:00:00Z
    MADRID and CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics, today announced that...


    Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences
    2026-05-13T12:00:00Z
    BRISBANE, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of...


    electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia
    2026-05-13T12:00:00Z
    ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings in JAMA Network Open titled,...


    ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial
    2026-05-13T12:00:00Z
    PRINCETON, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today...


    INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point
    2026-05-13T12:00:00Z
    Alliance launches with 26 founding companies to develop a national strategy for U.S. biotechnology leadership


    Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston
    2026-05-13T12:00:00Z
    SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the...


    Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update
    2026-05-13T12:00:00Z
    The Company intends to submit a Biologics License Application (BLA) for TARA-002 in Lymphatic Malformations (LMs) in 2H 2027


    Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks
    2026-05-13T12:00:00Z
    Preliminary blinded CR rate for the first 45 subjects in the trial approximates 30% and represents ~67% improvement vs. standard of careFirst 45-subject data unblinding expected before June 30, 2026Program...


    ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President
    2026-05-13T12:00:00Z
    SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering patients and their caregivers to better protect against severe allergic reactions...


    Valitor to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
    2026-05-13T12:00:00Z
    BERKELEY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering a new generation of ophthalmic medicines, today announced that chief executive officer Gregory D. Kunst will share...


    Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus
    2026-05-13T12:00:00Z
    First-in-human study evaluates weekly IV Sapu003 in advanced mTOR-sensitive solid tumors, including HR+/HER2- breast cancer, RCC, NETs, TSC-associated tumors, and HCC


    InnoCare Announce First Subject Dosed in Phase 1 Clinical Trial of ICP-054, a Novel Potentially Best-in-Class Oral IL-17AA/AF Inhibitor
    2026-05-13T11:43:28Z
    - Phase 1 trial designed to evaluate the safety, tolerability, and pharmacokinetic properties of ICP-054 (ZB021) in healthy volunteers - Phase 1 SAD and MAD data expected by year-end 2026


    Dyne Therapeutics to Participate in Upcoming Investor Conferences
    2026-05-13T11:30:00Z
    WALTHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today...


    Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update
    2026-05-13T11:30:00Z
    Q1 total revenue of $179.1M includes estimated license revenue from Genevant related to litigation settlement with Moderna


    Pyxis Oncology to Participate in Upcoming Investor Conferences
    2026-05-13T11:30:00Z
    BOSTON, May 13, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that management will participate in the following...


    Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update
    2026-05-13T11:30:00Z
    - Three patients treated with ZEVASKYN® in Q1 2026 -


    BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights
    2026-05-13T11:30:00Z
    Revenue grew approximately 35% year-over-year to $15.5 million for Q1 2026


    Palvella Therapeutics Announces Uplisting to the Nasdaq Global Market
    2026-05-13T11:30:00Z
    Uplisting reflects Palvella’s continued progress advancing potential first-in-disease therapies for serious, rare skin diseases and vascular malformations


    BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
    2026-05-13T11:30:00Z
    PHILADELPHIA and VANCOUVER, British Columbia, May 13, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies...


    Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
    2026-05-13T11:30:00Z
    Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as a once-weekly injection and a once-daily oral pill for the treatment of obesity and overweight


    Altimmune Announces First Quarter 2026 Financial Results and Business Update
    2026-05-13T11:30:00Z
    Initiation of PERFORMA Phase 3 MASH trial planned for second half 2026


    MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA
    2026-05-13T11:30:00Z
    TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today announced its...


    PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results
    2026-05-13T11:30:00Z
    Initiated NDA Submission to the FDA for D-PLEX₁₀₀ ; Completion Expected Imminently


    Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress
    2026-05-13T11:25:00Z
    Case study presented highlighted clinical experience with revyve® in complex wound care

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.